Avantor Inc
AVTR12.925USD
-2.574-16.61%
Fechamento 04/25, 16:00（ET）Cotações atrasadas em 15 min
8.80BValor de mercado
12.37P/L TTM
Mais detalhes de Avantor Inc Empresa
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Informações da empresa
Código da empresaAVTR
Nome da EmpresaAvantor Inc
Data de listagemMay 17, 2019
Fundado em2016
CEOMr. Michael Stubblefield
Número de funcionários13500
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 17
Endereço- -
Cidade- -
Bolsa de valoresNYSE Consolidated
País- -
Código postal- -
Telefone- -
Site- -
Código da empresaAVTR
Data de listagemMay 17, 2019
Fundado em2016
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.86M
+10.24%
Mr. James (Jim) Bramwell
Mr. James (Jim) Bramwell
Executive Vice President - Sales and Customer Excellence
Executive Vice President - Sales and Customer Excellence
425.12K
+29.52%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
321.36K
+0.42%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
79.50K
-0.71%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
49.59K
+42.57%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
39.90K
+3.45%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
39.09K
-47.24%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
34.97K
+3.96%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Independent Director
Independent Director
22.73K
-27.17%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael Stubblefield
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.86M
+10.24%
Mr. James (Jim) Bramwell
Mr. James (Jim) Bramwell
Executive Vice President - Sales and Customer Excellence
Executive Vice President - Sales and Customer Excellence
425.12K
+29.52%
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
321.36K
+0.42%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
79.50K
-0.71%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
49.59K
+42.57%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Proprietary materials & consumables
3.62B
53.29%
Third party materials & consumables
3.17B
46.71%
Por RegiãoUSD
Nome
Receita
Proporção
United States
3.55B
52.33%
All other countries
3.23B
47.67%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Proprietary materials & consumables
3.62B
53.29%
Third party materials & consumables
3.17B
46.71%
Acionista
Tempo de atualização: sex, 11 de abr
Tempo de atualização: sex, 11 de abr
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Dodge & Cox
14.55%
The Vanguard Group, Inc.
9.34%
BlackRock Institutional Trust Company, N.A.
8.13%
T. Rowe Price Investment Management, Inc.
6.07%
Barrow Hanley Global Investors
4.48%
Other
57.43%
Estatísticas dos acionistas
Acionista
Proporção
Dodge & Cox
14.55%
The Vanguard Group, Inc.
9.34%
BlackRock Institutional Trust Company, N.A.
8.13%
T. Rowe Price Investment Management, Inc.
6.07%
Barrow Hanley Global Investors
4.48%
Other
57.43%
Tipo
Acionista
Proporção
Investment Advisor/Hedge Fund
47.65%
Investment Advisor
41.49%
Pension Fund
4.83%
Private Equity
2.06%
Hedge Fund
1.77%
Bank and Trust
1.61%
Family Office
1.39%
Research Firm
1.23%
Individual Investor
1.23%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
1115
705.26M
103.50%
-65.96M
2024Q4
1156
702.95M
103.24%
-73.39M
2024Q3
1145
700.88M
103.10%
-38.62M
2024Q2
1147
666.63M
98.14%
-52.63M
2024Q1
1136
657.58M
96.83%
-81.17M
2023Q4
1152
657.17M
97.18%
-48.15M
2023Q3
1143
643.33M
95.20%
-49.55M
2023Q2
1149
625.74M
92.71%
-61.95M
2023Q1
1138
629.07M
93.23%
-29.97M
2022Q4
1103
608.41M
90.30%
-53.60M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
99.15M
14.55%
+30.73M
+44.91%
Dec 31, 2024
The Vanguard Group, Inc.
63.68M
9.34%
+1.22M
+1.96%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
55.40M
8.13%
+1.68M
+3.13%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
41.36M
6.07%
-25.74M
-38.36%
Dec 31, 2024
Barrow Hanley Global Investors
30.53M
4.48%
+8.94M
+41.39%
Dec 31, 2024
State Street Global Advisors (US)
23.31M
3.42%
+939.14K
+4.20%
Dec 31, 2024
CPP Investment Board
21.04M
3.09%
+112.64K
+0.54%
Dec 31, 2024
Janus Henderson Investors
18.14M
2.66%
+443.50K
+2.51%
Dec 31, 2024
New Mountain Capital, LLC
14.00M
2.05%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
11.23M
1.65%
+81.54K
+0.73%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
John Hancock Fundamental All Cap Core ETF
1.56%
Otter Creek Focus Strategy ETF
1.38%
Harbor Long-Short Equity ETF
1.12%
BNY Mellon Women's Opportunities ETF
1.11%
Vanguard S&P Mid-Cap 400 Value Index Fund
1.02%
SPDR S&P 400 Mid Cap Value ETF
0.76%
iShares S&P Mid-Cap 400 Value ETF
0.71%
Nuveen ESG Mid-Cap Value ETF
0.56%
Vanguard S&P Mid-Cap 400 Index Fund
0.5%
iShares ESG Select Screened S&P Mid-Cap ETF
0.43%
Ver Mais
John Hancock Fundamental All Cap Core ETF
Proporção1.56%
Otter Creek Focus Strategy ETF
Proporção1.38%
Harbor Long-Short Equity ETF
Proporção1.12%
BNY Mellon Women's Opportunities ETF
Proporção1.11%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proporção1.02%
SPDR S&P 400 Mid Cap Value ETF
Proporção0.76%
iShares S&P Mid-Cap 400 Value ETF
Proporção0.71%
Nuveen ESG Mid-Cap Value ETF
Proporção0.56%
Vanguard S&P Mid-Cap 400 Index Fund
Proporção0.5%
iShares ESG Select Screened S&P Mid-Cap ETF
Proporção0.43%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados